FDA issued a Warning Letter to CP Pharmaceuticals on 11/16/2016 for a later inspection.
483 CP Pharmaceuticals Sep 2013

483 CP Pharmaceuticals Sep 2013

Michael Charles FDA$119.00 - Available Now

FDA investigators audited the CP Pharmaceuticals - Wrexham, United Kingdom facility and issued inspectional observations (via FDA 483) on 10 Sep 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 10 Sep 2013
  • Location: Wrexham, United Kingdom
  • FEI: 3003369660
Add To Cart